← Leaderboards
Lukkana Suksanpaisan
Imanis Life Sciences, Llc
$828,879
Attributed
$2,018,288
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2015–18$2M$1.5M$1M$500K$0
'15
'16
'17
'18
Funding mix
By agency
NIH$2,018,288 · 3
By mechanism
R44$1,815,534 · 2
R43$202,754 · 1
Top collaborators
- Rosa Maria Diaz2 shared
- Bradley C. Leibovich2 shared
- Yasuhiro Ikeda1 shared
- Stephen J Russell1 shared
Others in their field
Top investigators on “Grant”
- David R. Weir · University Of Michigan At Ann Arbor$373,949,788
- David Heimbrook · Leidos Biomedical Research, Inc.$341,196,902
- Eric S Lander · Whitehead Institute For Biomedical Res$323,181,457
- Jeffrey P Krischer · University Of South Florida$258,583,867
- Lawrence Corey · Fred Hutchinson Cancer Center$253,286,867
- Barton F Haynes · Duke University$243,251,908
Research focus
GrantIn VitroMediatingClinicMonitorDesignClinical Trials DesignDiagnosisCessation Of LifeAnticancer ActivityClinical TrialsBcg VaccineCystectomyCytolysisChemotherapyBloodBladder TissueCancer TherapyCancer CellCancer Cell LineCancer EtiologyCancer ImmunotherapyCancer PatientBladder Neoplasm
Grant awards (4)
INTRAVESICAL ONCOLYTIC THERAPY FOR BLADDER CANCER$924,838
R44 · FY2018 · CA
Phase 2: NIS proteins with altered anion specificity$733,941
R44 · FY2018 · TR · contact PI
INTRAVESICAL ONCOLYTIC THERAPY FOR BLADDER CANCER$156,755
R44 · FY2017 · CA
Longitudinal In Vivo Imaging of NIS Expressing Stem Cells$202,754
R43 · FY2015 · GM · contact PI